StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Filana Therapeutics's market cap was $23.29M on Nov 11, 2026, against $157.00M a year earlier. Over the last 5 years it ranged from $23.29M to $1.77B, with a median of $856.99M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$23.29M-75.7%
2025Dec 31, 2025$95.65M-15.5%
2024Dec 31, 2024$113.22M-88.1%
2023Dec 29, 2023$948.34M-19.9%
2022Dec 30, 2022$1.18B-32.3%
2021Dec 31, 2021$1.75B+902.4%
2020Dec 31, 2020$174.45M+94.8%
2019Dec 31, 2019$89.54M+511.8%
2018Dec 31, 2018$14.64M-44.5%
2017Dec 29, 2017$26.38M+0.3%
2016Dec 30, 2016$26.31M-66.9%
2015Dec 31, 2015$79.37M-13.9%
2014Dec 31, 2014$92.15M-57.8%
2013Dec 31, 2013$218.54M+20.6%
2012Apr 30, 2012$181.16M-12.4%
2011Jul 29, 2011$206.83M–

More Filana Therapeutics figures

See a number that looks wrong?